Intellia Therapeutics (NTLA) PT Lowered to $86 at SVB Leerink
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.09 +1.51%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
SVB Leerink analyst Mani Foroohar lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $86.00 (from $90.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
